Table 5.
Treatment outcome | Yeast | Mold | p value |
---|---|---|---|
Visual Acuity (VA) |
n = 39 (51 eyes) |
n = 14 (16 eyes) |
|
Presenting mean |
1.15 (± 0.78) |
1.80 (± 0.80) |
0.008 |
logMAR VA (+/− SD) | |||
Final mean logMAR |
1.05 (± 1.01) |
1.97 (± 1.18) |
0.005 |
VA (± SD) | |||
Change mean |
0.11 (± 0.98) |
−0.17 (± 1.24) |
0.384 |
logMAR VA (± SD) | |||
Multiple IVF injections |
17/51 (33.3%) |
8/16 (50.0%) |
0.229 |
Retinal detachment |
15/49 (30.6%) |
2/16 (12.5%) |
0.201 |
Cataract |
11/49 (22.4%) |
1/16 (6.25%) |
0.147 |
Enucleation | 0/51 (0.0%) | 4/16 (25.0%) | < 0.001 |
SD, standard deviation; IVF, intravitreal antifungal; Student’s t test used for statistical analysis of presenting, final, and change in VA; Pearson chi-square test used for statistical analysis of retinal detachment, cataract formation, and enucleation rate.